This is a machine translation provided by the European Commission’s eTranslation service to help you understand this page. Please read the conditions of use.
The NGF system and its interplay with endocannabinoid signalling, from peripheral sensory terminals to the brain: new targets for the development of next generation drugs for neuropathic pain